If you believe you're at high risk for breast cancer, consider joining a special program at the HonorHealth Research Institute.
Jasgit Sachdev, MD, lead investigator for the HonorHealth Breast Cancer Prevention and Early Detection Program, and her care team offer high-risk women a personalized approach to breast cancer risk assessment and prevention.
They understand the concern you have about a possible diagnosis of breast cancer in the future, not only for you but also for your family. These researchers will evaluate your personal and family history, plus your genetic makeup, to identify if you're at high risk for the disease. It's the most commonly diagnosed cancer and the second leading cause of cancer-related death in women.
At this groundbreaking breast clinic you'll also benefit from:
- Risk-reduction measures.
- New approaches for screening.
- Long-term surveillance and follow-up.
- Counseling about preventive therapies.
- Recommendations on lifestyle modifications.
- Novel approaches for screening.
- Chemoprevention such as tamoxifen.
- Risk-reduction surgery, if appropriate.
- Opportunities to participate in clinical trials that explore new screening methods and diagnostic techniques.
- Collaboration with community healthcare providers to make sure you're receiving quality preventive care.
Referral criteria for the program
To be eligible for the program, you need to have one or more of these factors in your personal or family health history:
- Diagnosis of a precancerous breast lesion.
- Ashkenazi Jewish heritage.
- A high lifetime risk of developing breast cancer based on predictive models (Tyrer-Cuzik, GAIL model, etc.).
- Extremely dense breast tissue on mammogram.
- A family history of breast and other cancers:
- A known genetic mutation in a cancer risk gene — BRCA1, BRCA2 or other cancer-risk-related gene mutation.
- A strong family history of certain cancers such as female or male breast cancers, especially if diagnosed at an early age.
- Ovarian, prostate and pancreatic cancer in close relatives (generally first- or second-degree relatives).
"We have made significant progress over the years in identifying and diagnosing breast cancer at an early stage, which has improved outcomes for women significantly," said Dr. Sachdev. "This program personalizes the screening process for all women based on their individual risks. We offer a tailored approach for higher-risk women based on innovative preventive strategies."
You can make an impact
Your participation in a high-risk clinic and in early detection/prevention clinical trials will contribute to more effective breast cancer prevention and early detection guidelines for current and future generations of women.